BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Diagnosis
132 results:

  • 1. A randomised controlled trial of Pre-Operative Oncotype DX testing in early-stage breast cancer (PRE-DX study) - Study protocol.
    Northgraves M; Cohen J; Harvey J; Huang C; Palmieri C; Pinder S; Roy P; Reynia S; Soares M; Cain H
    PLoS One; 2024; 19(3):e0300339. PubMed ID: 38489298
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. cancer mortality and morbidity among patients with schizophrenia: A hospital-based cohort study, 1992-2020.
    Drevinskaite M; Kaceniene A; Patasius A; Stukas R; Germanavicius A; Miseikyte E; Urbonas V; Smailyte G
    Acta Psychiatr Scand; 2024 Mar; 149(3):234-243. PubMed ID: 38173088
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Performance Metrics of Screening Digital breast Tomosynthesis Based on Years Since a Prior breast cancer diagnosis.
    Do D; Mercaldo S; Bahl M
    AJR Am J Roentgenol; 2024 Mar; 222(3):e2330419. PubMed ID: 38117100
    [No Abstract]    [Full Text] [Related]  

  • 4. Components of the tumor immune microenvironment based on m-IHC correlate with prognosis and subtype of triple-negative breast cancer.
    Lin L; Li H; Wang X; Wang Z; Su G; Zhou J; Sun S; Ma X; Chen Y; You C; Gu Y
    Cancer Med; 2023 Dec; 12(24):21639-21650. PubMed ID: 38059408
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Determinants of Patient Delay among Women with Carcinoma breast.
    J SS; Rohini AM; Thajudheen RB; Elavally S
    Asian Pac J Cancer Prev; 2023 Sep; 24(9):3109-3115. PubMed ID: 37774062
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Hypothetical Interventions on Diet Quality and Lifestyle Factors to Improve breast cancer Survival: The Pathways Study.
    Ergas IJ; Bradshaw PT; Cespedes Feliciano EM; Roh JM; Kwan ML; Laraia B; Madsen KA; Yao S; Thomsen C; Kushi LH
    Cancer Epidemiol Biomarkers Prev; 2023 Dec; 32(12):1716-1725. PubMed ID: 37721486
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Plasma hPG
    Prieur A; Harper A; Khan M; Vire B; Joubert D; Payen L; Kopciuk K
    BMC Cancer; 2023 Apr; 23(1):305. PubMed ID: 37016331
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Patient Registry and Outcomes for breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Updated Report 2012-2020.
    McCarthy CM; Roberts J; Mullen E; Loyo-Berrios N; Clemens MW; Yoon SW; Levinson H; Sommers K; Hume K; Carr L
    Plast Reconstr Surg; 2023 Oct; 152(4S):16S-24S. PubMed ID: 36995215
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Pandemic Phase-Adjusted Analysis of COVID-19 Outcomes Reveals Reduced Intrinsic Vulnerability and Substantial Vaccine Protection From Severe Acute Respiratory Syndrome Coronavirus 2 in Patients With breast cancer.
    Tagliamento M; Gennari A; Lambertini M; Salazar R; Harbeck N; Del Mastro L; Aguilar-Company J; Bower M; Sharkey R; Dalla Pria A; Plaja A; Jackson A; Handford J; Sita-Lumsden A; Martinez-Vila C; Matas M; Miguel Rodriguez A; Vincenzi B; Tonini G; Bertuzzi A; Brunet J; Pedrazzoli P; D'Avanzo F; Biello F; Sinclair A; Lee AJX; Rossi S; Rizzo G; Mirallas O; Pimentel I; Iglesias M; Sanchez de Torre A; Guida A; Berardi R; Zambelli A; Tondini C; Filetti M; Mazzoni F; Mukherjee U; Diamantis N; Parisi A; Aujayeb A; Prat A; Libertini M; Grisanti S; Rossi M; Zoratto F; Generali D; Saura C; Lyman GH; Kuderer NM; Pinato DJ; Cortellini A
    J Clin Oncol; 2023 May; 41(15):2800-2814. PubMed ID: 36720089
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Premature ovarian insufficiency in female adolescent and young adult survivors of non-gynecological cancers: a population-based cohort study.
    Flatt SB; Baillargeon A; McClintock C; Pudwell J; Velez MP
    Reprod Health; 2023 Jan; 20(1):4. PubMed ID: 36593491
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Disease-free survival does not differ according to fertility preservation technique for young women with breast cancer.
    Sonigo C; Amsellem N; Mayeur A; Laup L; Pistilli B; Delaloge S; Eustache F; Sifer C; Rakrouki S; Benoit A; Peigné M; Grynberg M
    Fertil Steril; 2023 Mar; 119(3):465-473. PubMed ID: 36473609
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Diagnostic performance of 2D-shear wave elastography in the diagnosis of breast cancer: a clinical appraisal of cutoff values.
    Bartolotta TV; Orlando AAM; Dimarco M; Zarcaro C; Ferraro F; Cirino A; Matranga D; Vieni S; Cabibi D
    Radiol Med; 2022 Nov; 127(11):1209-1220. PubMed ID: 36114930
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Job loss, return to work, and multidimensional well-being after breast cancer treatment in working-age Black and White women.
    Emerson MA; Reeve BB; Gilkey MB; Elmore SNC; Hayes S; Bradley CJ; Troester MA
    J Cancer Surviv; 2023 Jun; 17(3):805-814. PubMed ID: 36103105
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Other Primary Malignancies in Patients with breast cancer Who Undergo Germline Panel Testing.
    Murphy BL; Yi M; Gutierrez Barrera AM; Tripathy D; Hunt KK; Arun BK
    Ann Surg Oncol; 2023 Mar; 30(3):1663-1668. PubMed ID: 36094691
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Dose-dependent relation between metformin and the risk of hormone receptor-positive, her2-negative breast cancer among postmenopausal women with type-2 diabetes.
    Chikermane SG; Sharma M; Abughosh SM; Aparasu RR; Trivedi MV; Johnson ML
    Breast Cancer Res Treat; 2022 Oct; 195(3):421-430. PubMed ID: 35969285
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive breast cancer.
    Abubakar M; Mullooly M; Nyante S; Pfeiffer RM; Aiello Bowles EJ; Cora R; Bodelon C; Butler E; Butcher D; Sternberg L; Troester MA; Weinmann S; Sherman M; Glass AG; Berrington de Gonzalez A; Gierach GL
    JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35583138
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla.
    Chuaychai A; Sriplung H
    PLoS One; 2022; 17(3):e0265417. PubMed ID: 35344552
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The symptomatic breast services in a university hospital: pandemic peak compared to the pre-pandemic year and future implications.
    Bansal GJ; Saleem Z
    Ir J Med Sci; 2022 Dec; 191(6):2475-2479. PubMed ID: 34988861
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Tumor aggressiveness is associated with cell integrity changes in breast cancer-surviving women: a follow-up study.
    Justa RMD; Damasceno NRT; Machado VMQ; da Costa SL; Oliveira KA; Verde SMML
    Nutr Hosp; 2022 Feb; 39(1):138-146. PubMed ID: 34939423
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Psychosocial impact of proactive rapid genetic counseling following breast cancer diagnosis.
    Kritzik R; Usoro E; Peshkin BN; Isaacs C; Valdimarsdottir HB; Willey S; O'Neill S; DeMarco T; Nusbaum R; Jandorf L; Kelleher S; Schwartz MD
    Psychooncology; 2022 May; 31(5):788-797. PubMed ID: 34921700
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.